Key facts
- Ellipsis Health’s last known valuation is $134.9M (Jun 2025).
- It has raised $75.1M across 1 recorded rounds; the latest was Seed Round ($4.0M) in Nov 2017.
- Notable investors include Alumni Ventures, Khosla Ventures, Gaingels, Greycroft, City Light Capital — 41 tracked in total.
- Ellipsis Health has filed 1 Form D with the SEC, most recently Dec 2017 ($4.0M sold to 15 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 41 names
- ·Watchlist + deal alerts for Ellipsis Health
Funding rounds
1 roundsAbout Ellipsis Health
Developer of an artificial intelligence-powered care management technology designed to automate and enhance clinical operations in healthcare settings. The company offers a platform featuring an emotionally intelligent virtual care manager that conducts autonomous patient calls, handles program enrollment, performs assessments and surveys, provides clinical support for care coordination and adherence, operates within infrastructure, and integrates with existing healthcare workflows, enabling healthcare institutions to expand capacity, reduce administrative tasks, and accelerate program enrollment.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2017
- Employees
- 70
- Website
- ellipsishealth.com/
- Ownership
- Privately Held (backing)
Ellipsis Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ellipsis Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ellipsis Health in its N-PORT filings yet. We sweep new filings monthly.